Nucleus Genomics is realizing the dream set into motion long ago by the Human Genome Project: to use the power of genomics to help people live lives that are as healthy and long as possible. Nucleus’s ...

Key opportunities in the AI clinical genomics interpretation market include the rising demand for precision medicine, wider adoption of AI-powered tools, advancements in predictive analytics, ...

Using a sequencing test developed at Intermountain Healthcare, Navican Genomics will use precision medicine to identify individual mutations within cancer tumors. This ability to target mutations will ...

August 31, 2023 - New research published today in Human Genetics and Genomics Advances reveals the difference between ‘what we say’ and ‘what people hear’ when engaging underrepresented communities ...

Few would deny that we are living in an AI Spring, yet many of the most popular advances have been in areas that are of marginal importance. While Large Language Models, chatbots, and generative ...

The human genome provides all the chemical instructions—expressed as DNA—to make a person. DNA is composed of two interlacing strands made up of nucleotide bases that pair across the two strands. We ...

In the last few years consumer genomics has grown in both its offerings and legitimacy. The industry that was once best known for telling clients if they were Italian or Hungarian is now securing its ...

AI-powered genomics tool, SCADE, significantly outperforms by more than doubling the accuracy of generic models, including those from OpenAI and DeepSeek, in solving single-cell genomics problems ...

Max Healthcare,one of the largest private sector healthcare services companies in India, andTata Institute for Genetics and Society (TIGS), a leading genomics research institute, today announced the ...

Max Healthcare has joined forces with the Tata Institute for Genetics and Society to enhance genomic medicine and improve patient outcomes through innovative research and personalized treatment ...

10x Genomics reported impressive Q2 performance with revenue growing by 28% YoY to reach $147M. The company's growth is driven by strong performance in both single-cell and spatial biology portfolios.